Typically it decided based on the results of clinical trials. We test different drugs with a large population of breast cancer patients and then whichever one is the most effective is the one that becomes the standard of care (i.e. the one that we choose first). If there are reasons why that person can’t tolerate that regimen then we may have to alter that plan. There may be sometimes where there are regimens that are equal and then it is based on side effects or logistics (how often the infusion ).
Note: Usernames have been made anonymous and profile images are not shown to protect the privacy of our members.
Note: All content on this site is informational and not a substitute for professional medical advice.
Always seek the advice of your physician or other qualified health provider with questions regarding your health.
Flag Content
Please expain why you are flagging this content. Thank you.
Only one answer per conversation per user. You may edit your answer though.
Question:
Optional: What context or background information is relevant to this request?
Notes:
The more clear and thorough your request, the more likely you will receive support.
Many of our members are learning from this information
or english might not be their first language.
Please use standard english and spell out all words.
For example, use 'you' instead of 'u'.
Call SHARE at: 866-891-2392
to speak directly to a trained breast cancer survivor for support and guidance.
3 Quick Ways You Can Help
1) Spread the word! Tell people you think might want some support. Tell medical professionals, health providers, and organizations.
2) Like us on Facebook and follow us on Twitter! 3) Volunteer - email us at volunteer@talkabouthealth.com for more information.